For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
June 30, 2023 at 13:28 PM EDT
Lower-price biosimilar competition for top-selling drug launching this weekend.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|